196 related articles for article (PubMed ID: 36690663)
1. PTK6 inhibits autophagy to promote uveal melanoma tumorigenesis by binding to SOCS3 and regulating mTOR phosphorylation.
Liu B; Yao X; Zhang C; Liu Y; Wei L; Huang Q; Wang M; Zhang Y; Hu D; Wu W
Cell Death Dis; 2023 Jan; 14(1):55. PubMed ID: 36690663
[TBL] [Abstract][Full Text] [Related]
2. LINC01278 Induces Autophagy to Inhibit Tumour Progression by Suppressing the mTOR Signalling Pathway.
Liu B; Yao X; Zhang C; Li W; Wang Y; Liao Q; Li Z; Huang Q; Zhang Y; Wu W
Oxid Med Cell Longev; 2023; 2023():8994901. PubMed ID: 36713034
[TBL] [Abstract][Full Text] [Related]
3.
Li P; He J; Yang Z; Ge S; Zhang H; Zhong Q; Fan X
Autophagy; 2020 Jul; 16(7):1186-1199. PubMed ID: 31462126
[TBL] [Abstract][Full Text] [Related]
4. PTK6 Localized at the Plasma Membrane Promotes Cell Proliferation and MigratiOn Through Phosphorylation of Eps8.
Shin WS; Shim HJ; Lee YH; Pyo M; Park JS; Ahn SY; Lee ST
J Cell Biochem; 2017 Sep; 118(9):2887-2895. PubMed ID: 28214294
[TBL] [Abstract][Full Text] [Related]
5. PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.
Park SH; Ito K; Olcott W; Katsyv I; Halstead-Nussloch G; Irie HY
Breast Cancer Res; 2015 Jun; 17(1):86. PubMed ID: 26084280
[TBL] [Abstract][Full Text] [Related]
6. Artemisinin Inhibits the Migration and Invasion in Uveal Melanoma via Inhibition of the PI3K/AKT/mTOR Signaling Pathway.
Farhan M; Silva M; Xingan X; Zhou Z; Zheng W
Oxid Med Cell Longev; 2021; 2021():9911537. PubMed ID: 34931134
[TBL] [Abstract][Full Text] [Related]
7. Protein-tyrosine kinase 6 promotes peripheral adhesion complex formation and cell migration by phosphorylating p130 CRK-associated substrate.
Zheng Y; Asara JM; Tyner AL
J Biol Chem; 2012 Jan; 287(1):148-158. PubMed ID: 22084245
[TBL] [Abstract][Full Text] [Related]
8. Interference of PTK6/GAB1 signaling inhibits cell proliferation, invasion, and migration of cervical cancer cells.
Li J; Yang N; Tian X; Ouyang L; Jiang M; Zhang S
Mol Med Rep; 2022 Sep; 26(3):. PubMed ID: 35894144
[TBL] [Abstract][Full Text] [Related]
9. PTK6 Potentiates Gemcitabine-Induced Apoptosis by Prolonging S-phase and Enhancing DNA Damage in Pancreatic Cancer.
Ono H; Basson MD; Ito H
Mol Cancer Res; 2015 Aug; 13(8):1174-84. PubMed ID: 26013168
[TBL] [Abstract][Full Text] [Related]
10. PTK6 promotes degradation of c-Cbl through PTK6-mediated phosphorylation.
Kang SA; Lee ST
Biochem Biophys Res Commun; 2013 Feb; 431(4):734-9. PubMed ID: 23352614
[TBL] [Abstract][Full Text] [Related]
11. Elucidating the role of the FoxO3a transcription factor in the IGF-1-induced migration and invasion of uveal melanoma cancer cells.
Yan F; Liao R; Farhan M; Wang T; Chen J; Wang Z; Little PJ; Zheng W
Biomed Pharmacother; 2016 Dec; 84():1538-1550. PubMed ID: 27881235
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic functions of PTK6 are enhanced by its targeting to plasma membrane but abolished by its targeting to nucleus.
Ie Kim H; Lee ST
J Biochem; 2009 Jul; 146(1):133-9. PubMed ID: 19304789
[TBL] [Abstract][Full Text] [Related]
13. Small molecule inhibitors reveal PTK6 kinase is not an oncogenic driver in breast cancers.
Qiu L; Levine K; Gajiwala KS; Cronin CN; Nagata A; Johnson E; Kraus M; Tatlock J; Kania R; Foley T; Sun S
PLoS One; 2018; 13(6):e0198374. PubMed ID: 29879184
[TBL] [Abstract][Full Text] [Related]
14. Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.
Ma S; Bao JYJ; Kwan PS; Chan YP; Tong CM; Fu L; Zhang N; Tong AHY; Qin YR; Tsao SW; Chan KW; Lok S; Guan XY
Gastroenterology; 2012 Sep; 143(3):675-686.e12. PubMed ID: 22705009
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of protein tyrosine kinase 6 contributes to tumor progression and metastasis in laryngeal squamous cell carcinoma.
Wu D; Zhang X; Liu Z; Yan H; Mai J; Zhao Z; Zhong Q; Liu X
Biochem Biophys Res Commun; 2018 Sep; 503(3):1378-1384. PubMed ID: 30029880
[TBL] [Abstract][Full Text] [Related]
16. PTK6 promotes cancer migration and invasion in pancreatic cancer cells dependent on ERK signaling.
Ono H; Basson MD; Ito H
PLoS One; 2014; 9(5):e96060. PubMed ID: 24788754
[TBL] [Abstract][Full Text] [Related]
17. Strategic Developments & Future Perspective on Gene Therapy for Breast Cancer: Role of mTOR and Brk/ PTK6 as Molecular Targets.
Sahu R; Pattanayak SP
Curr Gene Ther; 2020; 20(4):237-258. PubMed ID: 32807051
[TBL] [Abstract][Full Text] [Related]
18. Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT.
Zheng Y; Gierut J; Wang Z; Miao J; Asara JM; Tyner AL
Oncogene; 2013 Sep; 32(36):4304-12. PubMed ID: 23027128
[TBL] [Abstract][Full Text] [Related]
19. PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer.
Wozniak DJ; Kajdacsy-Balla A; Macias V; Ball-Kell S; Zenner ML; Bie W; Tyner AL
Nat Commun; 2017 Nov; 8(1):1508. PubMed ID: 29142193
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic Deregulation of Protein Tyrosine Kinase 6 Promotes Carcinogenesis of Oral Squamous Cell Carcinoma.
Hsieh YP; Chen KC; Chen MY; Huang LY; Su AY; Chiang WF; Huang WT; Huang TT
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]